000788.SZ
PKU HealthCare Corp., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.51
−2.13%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.2B | 1.5B | 2.1B | 2.2B | 2.1B |
| Cost of Revenue | 827.0M | 1.1B | 1.5B | 1.5B | 1.3B |
| Gross Profit | 368.2M | 415.6M | 552.5M | 711.9M | 772.1M |
| Operating Expenses | |||||
| R&D Expense | 26.5M | 26.9M | 27.0M | 27.8M | 14.7M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 109.1M | 109.5M | 109.8M | 117.3M | 109.6M |
| Selling & Marketing Expense | 95.8M | 115.9M | 202.2M | 459.8M | 543.7M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 235.8M | 258.0M | 349.2M | 618.5M | 691.2M |
| Cost and Expenses | 1.1B | 1.3B | 1.9B | 2.1B | 2.0B |
| Operating Income (EBIT) | 120.1M | 141.9M | 172.0M | 78.4M | 71.5M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 79.4M | 102.7M | 172.4M | 74.3M | 70.6M |
| Income Tax Expense | 15.2M | 19.8M | 34.4M | 29.9M | 15.2M |
| Bottom Line | |||||
| Net Income | 64.2M | 82.9M | 138.0M | 44.4M | 55.6M |
| Earnings from Cont. Ops | 64.2M | 82.9M | 138.0M | 44.4M | 55.4M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 64.2M | 82.9M | 138.0M | 44.4M | 55.6M |
| Per Share | |||||
| Basic EPS | CN¥0.11 | CN¥0.14 | CN¥0.23 | CN¥0.07 | CN¥0.09 |
| Diluted EPS | CN¥0.11 | CN¥0.14 | CN¥0.23 | CN¥0.07 | CN¥0.09 |
| Revenue Per Share | CN¥2.01 | CN¥2.49 | CN¥3.46 | CN¥3.68 | CN¥3.49 |
| Shares | |||||
| Basic Shares Outstanding | 595.9M | 595.9M | 596.1M | 596.2M | 596.0M |
| Diluted Shares Outstanding | 595.9M | 595.9M | 596.1M | 596.2M | 596.0M |
| Profitability Metrics | |||||
| EBITDA | — | 173.6M | 202.2M | 107.4M | 97.6M |
| D&A | — | 31.7M | 30.2M | 28.9M | 26.1M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026